InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Wellborn Gayle Furgurson, 董事. Director active across 1 company, notably Healthequity, INC.. Aggregated, 10 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €306k. Activity tracked since 1 February 2022. The latest transaction was filed on 12 December 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Wellborn Gayle Furgurson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
2,877 股Common StockSEC:0001712960-26-000004:0
4,339 股@ US$50.4125.8% 占其流量Common StockSEC:0001712960-25-000004:0
2,003 股0Common StockSEC:0001415889-25-018540:0
5,297 股@ US$47.2143.1% 占其流量Common StockSEC:0001415889-24-019483:0
2,543 股0Common StockSEC:0001415889-24-019409:0
3,164 股0Common StockSEC:0001415889-23-010324:0
5,237 股@ US$62.0056.9% 占其流量Common StockSEC:0001415889-22-012624:0
2,996 股0Common StockSEC:0001415889-22-006997:0
1,455 股0Common StockSEC:0001179110-22-002747:0
727 股0Common StockSEC:0001179110-22-000753:0
10 条申报中的 10 条
About Wellborn Gayle Furgurson
Wellborn Gayle Furgurson is Administrateur and a Director at Healthequity, INC. She has 10 filings in total. Across the 10 recent sampled filings, reported sales total 305547 EUR, the date range runs from 2022-02-03 to 2026-06-29, and the most frequent transaction nature is Attribution.
